MacroGenics Announces Development Milestone Achieved in Retifanlimab (MGA012) Collaboration with Incyte
$15 Million milestone triggered by initiation of Phase 3 clinical trial in NSCLC by IncyteROCKVILLE, MD, Sept. 21, 2020 (GLOBE […]
BridgeBio Pharma’s Calcilytix Therapeutics Initiates Phase 2 Study Of Encaleret For Autosomal Dominant Hypocalcemia Type 1 (ADH1)
Topline proof-of-concept results in ADH1 anticipated in 2021Currently, there are no approved therapies for ADH1PALO ALTO, Calif., Sept. 21, 2020 […]
Crinetics Pharmaceuticals Receives Rare Pediatric Disease Designation from FDA for CRN04777 for the Treatment of Congenital Hyperinsulinism
SAN DIEGO, Sept. 21, 2020 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on […]
Theratechnologies Announces Preliminary Third-Quarter Fiscal 2020 Financial Results
MONTREAL, Sept. 21, 2020 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the […]
Angus Mining receives orders revoking Cease Trade Orders
TORONTO, Sept. 21, 2020 (GLOBE NEWSWIRE) — Angus Mining Inc. (the “Company”) is very pleased to announce that the securities […]
Plug Power To Host Virtual Plug Symposium On September 24, 2020
LATHAM, N.Y., Sept. 21, 2020 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a leading provider of clean hydrogen and […]
Adicet Bio, Inc. Announces Proposed Public Offering of Common Stock
MENLO PARK, Calif. and BOSTON, Sept. 21, 2020 (GLOBE NEWSWIRE) — Adicet Bio, Inc. (“Adicet”) (Nasdaq: ACET), a biotechnology company […]
Axsome Therapeutics Announces Expedited Development of AXS-12 for the Treatment of Narcolepsy Based on FDA Breakthrough Therapy Meeting
Single Phase 3 trial to be conducted to support an NDA filing of AXS-12 in the treatment of narcolepsy; trial […]
Trevena, Inc. Announces Presentations at the Virtual 2020 American College of Clinical Pharmacology Annual Meeting
—Live presentation highlighting TRV027 as a potential treatment for COVID-19 acute respiratory distress syndrome (ARDS) / abnormal clottingPosters on OLINVYK […]
Precision BioSciences and SpringWorks Therapeutics Announce Clinical Collaboration to Evaluate PBCAR269A in Combination with Nirogacestat in Patients with Relapsed or Refractory Multiple Myeloma
DURHAM, N.C. and STAMFORD, Conn., Sept. 21, 2020 (GLOBE NEWSWIRE) — Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology […]
